Skip to search formSkip to main contentSkip to account menu

Non-nucleoside Reverse Transcriptase Inhibitor

Known as: NNRTI 
A substance structurally unlike a nucleoside molecule that is capable of inhibiting the function of a reverse transcriptase. These compounds do not… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Programs that monitor local, national, and regional levels of transmitted HIV-1 drug resistance inform treatment guidelines and… 
Highly Cited
2006
Highly Cited
2006
Objective:To compare the prevalence of resistance by adherence level in patients treated with non-nucleoside reverse… 
Review
2005
Review
2005
The 2008 BHIVA Guidelines have been updated to incorporate all the new relevant information (including presentations at the 15th… 
Highly Cited
2005
Highly Cited
2005
ABSTRACT To investigate the extent to which drug resistance mutations are missed by standard genotyping methods, we analyzed the… 
Highly Cited
2004
Highly Cited
2004
Anti-AIDS drug candidate and non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC125-R165335 (etravirine) caused an initial… 
Highly Cited
2003
Highly Cited
2003
Objective: To determine the prevalence of risk factors for cardiovascular disease (CVD) among HIV-infected persons, and to… 
Review
2002
Review
2002
OBJECTIVE New information warrants updated recommendations for the 4 central issues in antiretroviral therapy: when to start…